New 5-FU Derivative EB-18 Shows Potency Against Resistant Cancers
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in ...
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in ...
Researchers built and validated a nomogram that predicts survival and identifies which elderly female lung cancer patients with bone metastases ...
Researchers have discovered that the calcium-rich bone microenvironment drives chemotherapy tolerance in osteosarcoma through an ORAI3–Ca²⁺–NFAT4–PINK1 mitophagy axis that can ...
A head-to-head study of women with early breast cancer finds that T-cell p16INK4a and DNA methylation clocks are only weakly ...
New research shows that the blood lipid protein ApoA2 promotes metastasis and chemotherapy resistance in hepatocellular carcinoma by activating an ...
The 2025 Chinese guidelines consolidate two decades of evidence into an updated roadmap for diagnosing, preventing and treating colorectal cancer ...
Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with ...
A dual PI3K/mTOR inhibitor, VDC597, suppresses signaling, kills canine lymphoma and leukemia cells in vitro, and synergizes with dexamethasone, according ...
A Japanese study finds that two simple postoperative blood markers can identify which patients over 70 with stage III colorectal ...
A rare case of isolated endobronchial Aspergillus fumigatus infection in a severely neutropenic lymphoma patient caused fatal respiratory failure within ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine